<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE OF REVIEW: This review examines recent literature on <z:e sem="disease" ids="C0041234" disease_type="Disease or Syndrome" abbrv="">Chagas disease</z:e> in the immunosuppressed host </plain></SENT>
<SENT sid="1" pm="."><plain>RECENT FINDINGS: <z:e sem="disease" ids="C0041234" disease_type="Disease or Syndrome" abbrv="">Chagas disease</z:e> in immunosuppressed patients may represent <z:hpo ids='HP_0011009'>acute</z:hpo> transmission in an organ recipient, or reactivation of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in an HIV-infected individual or patient receiving cardiac transplantation for Chagas <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Transplantation of the kidney or liver from an infected donor resulted in transmission in 18-19 and 29%, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>Prospective monitoring usually detects <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> before symptom <z:hpo ids='HP_0003674'>onset</z:hpo>; early treatment is highly effective </plain></SENT>
<SENT sid="4" pm="."><plain>In heart transplant patients, reactivation symptoms include <z:hpo ids='HP_0001945'>fever</z:hpo>, <z:mp ids='MP_0001856'>myocarditis</z:mp> and <z:mp ids='MP_0001212'>skin lesions</z:mp>, and may mimic rejection </plain></SENT>
<SENT sid="5" pm="."><plain>Approximately 20% of HIV- Trypanosoma cruzi infected patients experience reactivation; manifestations include <z:e sem="disease" ids="C0025309" disease_type="Disease or Syndrome" abbrv="">meningoencephalitis</z:e> and/or <z:mp ids='MP_0001856'>myocarditis</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>SUMMARY: Transplantation of the heart from a T. cruzi-infected donor is contraindicated; use of other organs can be considered </plain></SENT>
<SENT sid="7" pm="."><plain>Guidelines recommend prospective monitoring rather than prophylactic treatment in recipients </plain></SENT>
<SENT sid="8" pm="."><plain>Posttransplant monitoring for <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> or reactivation relies on PCR, culture and microscopy of blood specimens regularly for at least 6 months </plain></SENT>
<SENT sid="9" pm="."><plain>Treatment employs standard courses of benznidazole or nifurtimox, and immune reconstitution for the HIV-coinfected patient </plain></SENT>
<SENT sid="10" pm="."><plain>Case reports suggest some HIV-T. cruzi-infected patients may benefit from secondary prophylaxis, but more data are needed to determine efficacy and specific regimens </plain></SENT>
</text></document>